October 3-6, 2019

CHICAGO MARRIOTT DOWNTOWN MAGNIFICENT MILE

This activity has been approved for 21.0 AMA PRA Category 1 Credit(s)™

Register 2019 Presentations

About the Symposium

Referred to as the most valuable breast cancer meeting worldwide for the practicing clinician, the Lynn Sage Breast Cancer Symposium provides 3.5 days of formal presentations and interactive case discussions. For over 20 years, this multidisciplinary CME program has been bringing together leading national and international medical, surgical, and radiation oncologists to present, debate, and evaluate cutting-edge technology and approaches in the management of breast cancer.

Progress across all aspects of patient care, including prevention, screening, detection, and survivorship, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, and novel biologic therapies are leading to new strategies and therapeutic options. The symposium focuses on the close cooperation required for effective multidisciplinary management of patients with breast cancer.

Agenda » Faculty » Accomodations » Fees & Other Important Information »

Lynn Sage Distinguished Lecture

De-Escalation of Systemic Therapy to Avoid Chemotherapy in Patients With Her2+ Early Breast Cancer: Is It Possible and in Whom?

C. Kent Osborne, MD
Baylor College of Medicine

Connie Moskow Memorial Lecture

Breast Cancer, Estrogen and Aging:
Implications for Survivors

Patricia Ganz, MD
UCLA

Chair
William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center
Northwestern University

Co-Chair
Monica Morrow, MD
Memorial Sloan Kettering Cancer Center
 

Co-Chair
V. Craig Jordan, OBE, PhD, DSc
MD Anderson Cancer Center
University of Texas

Co-Chair
Nora Hansen, MD
Robert H. Lurie Comprehensive Cancer Center
Northwestern University

AVAILABLE AWARDS

TOPICS

  • Supportive Oncology and Special Populations
  • Breast Pathology for the Non-Pathologist
  • Challenging Clinical Cases
  • Diagnosis and Prevention of Invasive Cancer
  • Management Dilemmas in Neoadjuvant Therapy
  • New Approaches to Poor Prognosis in Breast Cancer
  • Common Clinical Problems
  • De-Escalating Therapy
Full Agenda »

MAILING LIST

Get information about registration and the latest news by subscribing to our email list.

TWITTER

Please join the conversation on Twitter before, during and after the conference by connecting with us @LurieCancer, and using the hashtag #LSBC19

FUTURE SYMPOSIA

September 10 - September 13, 2020

September 30 - October 3, 2021

© 2018 Robert H. Lurie Comprehensive Cancer Center